P2Y12 Inhibitor Monotherapy or Dual Antiplatelet Therapy After Complex Percutaneous Coronary Interventions.

P2Y12 Inhibitor Monotherapy or Dual Antiplatelet Therapy After Complex Percutaneous Coronary Interventions. J Am Coll Cardiol. 2023 02 14; 81(6):537-552.

View in: PubMed

subject areas

Aspirin
Drug Therapy, Combination
Hemorrhage
Humans
Percutaneous Coronary Intervention
Platelet Aggregation Inhibitors
Purinergic P2Y Receptor Antagonists
Treatment Outcome

authors with profiles

Usman Baber